Picture of Glenmark Pharmaceuticals logo

GLENMARK Glenmark Pharmaceuticals Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-0.71%
3m+7.76%
6m+6.2%
1yr+68.43%
Volume Change (%)
10d/3m+14.62%
Price vs... (%)
52w High-2.3%
50d MA+4.88%
200d MA+18.3%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)22.74
PEG Ratio (f)0.63
EPS Growth (f)56.83%
Dividend Yield (f)0.31%
Valuation (ttm)IndustryMarket
Price to Book Value2.78
Price to Tang. Book3.76
Price to Free Cashflow842.41
Price to Sales2.21
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-4.96%
Return on Equity-13.03%
Operating Margin-6.22%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueIN₹m98,654.68106,409.69109,439.29123,049.03115,832.35124,731.25141,185.854.94%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+3.84-6.47+24.56+19.97-70.88+132.12+54.13n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Glenmark Pharmaceuticals EPS forecast chart

Profile Summary

Glenmark Pharmaceuticals Limited is an India-based global pharmaceutical company. The Company is focused on building a global formulation business with branded, generics and over the counter (OTC) segments in the therapy areas of dermatology, respiratory and oncology. The Company also has a regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. Its product portfolio includes topical products, liquids, respiratory MDI/DPI, complex injectables and biologics, and oral solids. The Company has a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand, Tiogiva in the United Kingdom and Tavulus in Spain, for the treatment of chronic obstructive pulmonary disease. Ryaltris, the Company's first branded specialty product globally, is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
November 18th, 1977
Public Since
December 10th, 1999
No. of Shareholders
285,461
No. of Employees
15,556
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconNational Stock Exchange of India
Shares in Issue
282,188,156
Blurred out image of a map
Address
B D S Marg, MUMBAI, 400099
Web
https://glenmarkpharma.com/
Phone
+91 2240189999
Contact
Harish Kuber
Auditors
SURESH SURANA & ASSOCIATES LLP

GLENMARK Share Price Performance

Upcoming Events for GLENMARK

Similar to GLENMARK

Picture of Aarey Drugs and Pharmaceuticals logo

Aarey Drugs and Pharmaceuticals

in flag iconNational Stock Exchange of India

Picture of Aarti Drugs logo

Aarti Drugs

in flag iconNational Stock Exchange of India

Picture of Aarti Pharmalabs logo

Aarti Pharmalabs

in flag iconNational Stock Exchange of India

Picture of Abbott India logo

Abbott India

in flag iconNational Stock Exchange of India

Picture of Accent Microcell logo

Accent Microcell

in flag iconNational Stock Exchange of India

FAQ